Drug
Vardenafil clinical trials
Also written Levitra.
- studies test it
- 61
- open now
- 1
- in phase 3
- 23
- first study started
- 2002
Keep track of what changes. Save the vardenafil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
61 studies that test it; most in 2003 (18)
| Year | Studies |
|---|---|
| 2002 | 4 |
| 2003 | 18 |
| 2004 | 9 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 5 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 3 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 11
- Phase 3
- 23
- Phase 4
- 25
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 46 · Other 15
Bayer (44) · Rabin Medical Center (2) · Damascus University (1) · GlaxoSmithKline (1) · Azienda USL Modena (1) · ViiV Healthcare (1) · McGuire Research Institute (1) · Hospital Authority, Hong Kong (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vardenafil is read from its arms, and is right about nine times in ten.
Testing it · 61
- Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaRecruitingPhase 3Tanta UniversityNCT06491108Written as Vardenafil 5 Mg Oral Tablet
- Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the NewbornCompletedPhase 1/2Damascus UniversityNCT06860399Written as Vardenafil
- Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?TerminatedPhase 2Cliniques universitaires Saint-Luc- Université Catholique de LouvainNCT01002534Written as Vardenafil
- Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain MetastasesTerminatedEarly Phase 1Cedars-Sinai Medical CenterNCT02279992Written as Vardenafil
- A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and DyslipidemiaCompletedPhase 4GlaxoSmithKlineNCT00379756Written as LEVITRA (vardenafil)
- Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic SyndromeCompletedPhase 4BayerNCT00738400Written as Vardenafil (Levitra, BAY38-9456)
- Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver CirrhosisStatus unknownPhase 4Medical University of ViennaNCT02344823Written as Vardenafil
- Assess Efficacy in Subjects With Traumatic Spinal Cord InjuryCompletedPhase 4BayerNCT00667966Written as Vardenafil (Levitra, BAY 38-9456), 10 mg
- FDA Phase IV - Commitment - Retinal Function StudyCompletedPhase 4BayerNCT00461565Written as Vardenafil (Levitra, BAY38-9456)
- BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.CompletedPhase 3BayerNCT00668057Written as Levitra (Vardenafil, BAY38-9456)
- Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile DysfunctionCompletedPhase 3BayerNCT00661596Written as Levitra (Vardenafil, BAY38-9456)
- Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm FunctionCompletedPhase 4BayerNCT00655590Written as Levitra (Vardenafil, BAY38-9456)
- Assessment of Duration of Erection With Vardenafil 10 mgCompletedPhase 4BayerNCT00663728Written as Levitra (Vardenafil, BAY38-9456)
- Efficacy and Safety of Vardenafil in Men With Erectile DysfunctionCompletedPhase 3BayerNCT00657644Written as Levitra (Vardenafil, BAY38-9456)
- A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.CompletedPhase 4BayerNCT00668096Written as Levitra (Vardenafil, BAY38-9456)
- BAY38-9456, 5/10/20mg, vs.Placebo in Erectile DysfunctionCompletedPhase 4BayerNCT00665054Written as Levitra (Vardenafil, BAY38-9456)
- Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study IICompletedPhase 4BayerNCT00377793Written as Levitra (Vardenafil, BAY38-9456)
- BAY38-9456 - Supportive Trial for Spinal InjuryCompletedPhase 3BayerNCT00652262Written as Levitra (Vardenafil, BAY38-9456)
- A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile DysfunctionCompletedPhase 3BayerNCT00654914Written as Levitra (Vardenafil, BAY38-9456)
- Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 HoursCompletedPhase 3BayerNCT00668018Written as Levitra (Vardenafil, BAY38-9456)
See all 61 studies that test vardenafil →
Given in every arm · 2 — vardenafil is usual care beside what is tested
- A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234CompletedPhase 1Respira Therapeutics, Inc.NCT05567367Written as Vardenafil Oral Tablet
- Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)CompletedPhase 4University of FlorenceNCT02450188Written as Vardenafil
Codes
What other systems call vardenafil · ClinicalTrials.gg INT006565
- MeSH (NLM) D000069058Vardenafil DihydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UCE6F4125HVARDENAFILConfirmed FDA, NLM, Wikidata
- RxNorm 306674Confirmed FDA, Wikidata
- Wikidata Q424161vardenafilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66650VardenafilOne source FDA
- DrugBank DB00862One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069058 | Vardenafil Dihydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UCE6F4125H | VARDENAFIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 306674 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424161 | vardenafil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66650 | Vardenafil | One source FDA |
| DrugBank | DB00862 | — | One source Wikidata |
Also registered as vardenafil dihydrochloride (UNII 5O8R96XMH7), vardenafil hydrochloride (UNII 5M8S2CU0TS · RxNorm 307306) and vardenafil hydrochloride anhydrous (UNII IF61NL91H3).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.